-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Boston Scientific, Lowers Price Target to $57

Benzinga·10/29/2026 18:25:42
Listen to the news
UBS analyst Patrick Wood maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $67 to $57.